Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-06

Clinical Trial Update: Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184) [Phase 2]

View source ↗

Summary

Phase 2 trial for FBS0701 (SSP-004184) in transfusion-related iron overload has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FBS0701 (SSP-004184) (FBS0701)

Snippet

Sponsor: Shire | Conditions: Iron Overload Due to Repeated Red Blood Cell Transfusions | Phase 2 | Status: TERMINATED | Results posted: 2015-08-06